Market Revenue Endocrine Testing Industry Capacity, Production | Page 3

Test Type Outlook (Revenue, USD Million, 2013 - 2024)
• Estradiol
• FSH
• hCG
• LH
• DHEAS
• Progesterone
• Testosterone
• TSH
• Prolactin
• Cortisol
• Insulin
• Others
Technology Outlook (Revenue, USD Million, 2013 - 2024)
• Tandem Mass Spectrometry
• Immunoassay
• Monoclonal & Polyclonal antibody technologies
• Sensor technology
• Clinical chemistry
• Others
End Use Outlook (Revenue, USD Million, 2013 - 2024)
• Hospital
• Commercial Laboratory
• Ambulatory Care Centers
• Others
Regional Outlook (Revenue, USD Million, 2013 - 2024)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China